Literature DB >> 16495005

Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury.

Zheng Gen Piao1, Ik-Hyun Cho, Chul Kyu Park, Jin Pyo Hong, Se-Young Choi, Sung Joong Lee, Seungbok Lee, Kyungpyo Park, Joong Soo Kim, Seog Bae Oh.   

Abstract

Glial activation is known to contribute to pain hypersensitivity following spinal sensory nerve injury. In this study, we investigated mechanisms by which glial cell activation in medullary dorsal horn (MDH) would contribute to tactile hypersensitivity following inferior alveolar nerve and mental nerve transection (IAMNT). Activation of microglia and astrocytes was monitored at 2 h, 1, 3, 7, 14, 28, and 60 days using immunohistochemical analysis with OX-42 and GFAP antibodies, respectively. Tactile hypersensitivity was significantly increased at 1 day, and this lasted for 28 days after IAMNT. Microglial activation, primarily observed in the superficial laminae of MDH, was initiated at 1 day, maximal at 3 days, and maintained until 14 days after IAMNT. Astrocytic activation was delayed compared to that of microglia, being more profound at 7 and 14 days than at 3 days after IAMNT. Both tactile hypersensitivity and glial activation appeared to gradually reduce and then return to the basal level by 60 days after IAMNT. There was no significant loss of trigeminal ganglion neurons by 28 days following IAMNT, suggesting that degenerative changes in central terminals of primary afferents might not contribute to glial activation. Minocycline, an inhibitor of microglial activation, reduced microglial activation, inhibited p38 mitogen-activated protein kinase (MAPK) activation in microglia, and significantly attenuated the development of pain hypersensitivity in this model. These results suggest that glial activation in MDH plays an important role in the development of neuropathic pain and activation of p38 MAPK in hyperactive microglia contributes to pain hypersensitivity in IAMNT model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495005     DOI: 10.1016/j.pain.2005.12.023

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  73 in total

Review 1.  Astrocyte-neuron communication: functional consequences.

Authors:  Sarrah Ben Achour; Olivier Pascual
Journal:  Neurochem Res       Date:  2012-06-06       Impact factor: 3.996

Review 2.  The effect of morphine on glial cells as a potential therapeutic target for pharmacological development of analgesic drugs.

Authors:  Haroon Hameed; Mariam Hameed; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2010-04

Review 3.  Tetracyclines and pain.

Authors:  Leandro F S Bastos; Antônio C P de Oliveira; Linda R Watkins; Márcio F D Moraes; Márcio M Coelho
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-27       Impact factor: 3.000

Review 4.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

Review 5.  Central mechanism of action of antimigraine prophylactic drugs.

Authors:  Gerardo Casucci; Veronica Villani; Fabio Frediani
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

6.  Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine.

Authors:  Zhi-Ye Zhuang; Yasuhiko Kawasaki; Ping-Heng Tan; Yeong-Ray Wen; Jing Huang; Ru-Rong Ji
Journal:  Brain Behav Immun       Date:  2006-12-15       Impact factor: 7.217

7.  Systemic minocycline differentially influences changes in spinal microglial markers following formalin-induced nociception.

Authors:  Kai Li; Kai-Yuan Fu; Alan R Light; Jianren Mao
Journal:  J Neuroimmunol       Date:  2010-03-04       Impact factor: 3.478

8.  Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture.

Authors:  W-W Li; T-Z Guo; X Shi; Y Sun; T Wei; D J Clark; W S Kingery
Journal:  Neuroscience       Date:  2015-09-16       Impact factor: 3.590

9.  A novel non-antibacterial, non-chelating hydroxypyrazoline derivative of minocycline inhibits nociception and oedema in mice.

Authors:  L F S Bastos; A Angusti; M C Vilaça; L A Merlo; E B Nascimento; L T S Rocha; A M Godin; A G R Solano; S Jarussophon; E A Nunan; Y Konishi; M M Coelho
Journal:  Br J Pharmacol       Date:  2008-07-28       Impact factor: 8.739

10.  Regulation of the trigeminal NR1 subunit expression induced by inflammation of the temporomandibular joint region in rats.

Authors:  Shuxing Wang; Grewo Lim; Ji Mao; Backil Sung; Jianren Mao
Journal:  Pain       Date:  2008-12-05       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.